Audited Results of Ajanta Pharma Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	4,322.04	3,971.12	3,411.27	3,140.64	2,718.59
Manufacturing Expenses	70.22	66.44	65.53	54.09	43.42
Personnel Expenses	1,010.90	834.16	720.41	585.87	498.11
Selling Expenses	5.76	4.49	5.02	4.78	1.62
Administrative Expenses	962.03	818.43	849.29	718	491.11
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	3,117.32	2,851.69	2,711.99	2,249.75	1,801.68
Operating Profit	1,204.72	1,119.43	699.28	890.89	916.91
Other Recurring Income	119.87	116.48	132.75	139.73	103.57
Adjusted PBDIT	1,324.59	1,235.91	832.03	1,030.62	1,020.48
Financial Expenses	4.60	6.80	5.23	9.12	6.90
Depreciation	139.93	132.16	126.95	120.96	111.49
Other Write offs	0	0	0	0	0
Adjusted PBT	1,180.06	1,096.95	699.85	900.54	902.09
Tax Charges	263.17	289.71	141.13	180.68	226.45
Adjusted PAT	916.89	807.24	558.72	719.86	675.64
Non Recurring Items	0	0	0	0	0
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	916.89	807.24	558.72	719.86	675.64
Equity Dividend	349.75	642.17	89.69	82.21	51.26
Preference Dividend	0	0	0	0	0
Retained Earnings	3,820.58	3,254.36	3,164.01	2,763.48	2,158.25

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article